Degradation and healing in a generalized neo-Hookean solid due to infusion of a fluid

The mechanical response and load bearing capacity of high performance polymer composites changes due to diffusion of a fluid, temperature, oxidation or the extent of the deformation. Hence, there is a need to study the response of bodies under such degradation mechanisms. In this paper, we study the effect of degradation and healing due to the diffusion of a fluid on the response of a solid which prior to the diffusion can be described by the generalized neo-Hookean model. We show that a generalized neo-Hookean solid - which behaves like an elastic body (i.e., it does not produce entropy) within a purely mechanical context - creeps and stress relaxes when infused with a fluid and behaves like a body whose material properties are time dependent. We specifically investigate the torsion of a generalized neo-Hookean circular cylindrical annulus infused with a fluid. The equations of equilibrium for a generalized neo-Hookean solid are solved together with the convection-diffusion equation for the fluid concentration. Different boundary conditions for the fluid concentration are also considered. We also solve the problem for the case when the diffusivity of the fluid depends on the deformation of the generalized neo-Hookean solid.Comment: 24 pages, 10 figures, submitted to Mechanics of Time-dependent Material

CVOT summit report 2023: new cardiovascular, kidney, and metabolic outcomes

The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform for in-depth discussions and exchange on recently completed outcomes trials including dapagliflozin (DAPA-MI), semaglutide (SELECT and STEP-HFpEF) and bempedoic acid (CLEAR Outcomes), and the advances they represent in reducing the risk of major adverse cardiovascular events (MACE), improving metabolic outcomes, and treating obesity-related heart failure with preserved ejection fraction (HFpEF). A broad audience of endocrinologists, diabetologists, cardiologists, nephrologists and primary care physicians participated in online discussions on guideline updates for the management of cardiovascular disease (CVD) in diabetes, heart failure (HF) and chronic kidney disease (CKD); advances in the management of type 1 diabetes (T1D) and its comorbidities; advances in the management of CKD with SGLT2 inhibitors and non-steroidal mineralocorticoid receptor antagonists (nsMRAs); and advances in the treatment of obesity with GLP-1 and dual GIP/GLP-1 receptor agonists. The association of diabetes and obesity with nonalcoholic steatohepatitis (NASH; metabolic dysfunction-associated steatohepatitis, MASH) and cancer and possible treatments for these complications were also explored. It is generally assumed that treatment of chronic diseases is equally effective for all patients. However, as discussed at the Summit, this assumption may not be true. Therefore, it is important to enroll patients from diverse racial and ethnic groups in clinical trials and to analyze patient-reported outcomes to assess treatment efficacy, and to develop innovative approaches to tailor medications to those who benefit most with minimal side effects. Other keys to a successful management of diabetes and comorbidities, including dementia, entail the use of continuous glucose monitoring (CGM) technology and the implementation of appropriate patient-physician communication strategies. The 10th Cardiovascular Outcome Trial Summit will be held virtually on December 5–6, 2024 (http://www.cvot.org)

Using indices of species’ potential range to inform conservation status

Assessments of conservation status are typically based on short-term extinction risk, but the value of indicators that compare the current state of species (e.g., abundance or distribution) to potential baselines is increasingly recognised. The use of baselines in conservation legislation is hindered by ambiguity in how baselines should be determined and interpreted, leading to inconsistent application. Here, we explored the use of species’ potential ranges as a consistent means of quantifying baselines for assessing species’ distributions, a key component of conservation status. Using breeding birds of Great Britain (GB) as a case study, we simulated where bird species would be expected to occur today in a modelled world without human land use. We calculated indices that contrasted these potential human-free ranges with realised ranges. Our analyses revealed that 42% of GB birds have wider realised than potential ranges and 28% have narrower realised than potential ranges. These indices could lead to reassessments of current conservation priorities. Eighteen species assigned ‘least concern’ status by the GB regional IUCN Red List had much narrower realised than potential ranges, suggesting that their ranges are in a more degraded state than currently recognised by Red List criteria. Some of these species are not under active conservation management and could be candidates for higher prioritisation. Our approach provides a systematic means of quantifying range baselines that is not reliant on variable historic data or expert opinion and, thereby, provides a step forward in resolving a major contemporary problem in conservation assessment: how to set baselines in conservation consistently. The insights produced are also of wider scientific and cultural relevance, revealing where species would likely exist today in the absence of historic human impacts. This could be used to identify areas where targeted restoration actions might lead to the return of historically extirpated species, or even to novel colonists